AzTrials
AzTrials

MTBI - Mild Traumatic Brain InjuryNCT05090007

Imaging of Injury Mechanism and Interaction of Intestinal Bacteria in Children With Mild Traumatic Brain Injury

An observational study of MTBI - Mild Traumatic Brain Injury, run by First Affiliated Hospital Xi'an Jiaotong University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Traumatic brain injury (TBI) is the leading cause of disability in children and young adults. Children with moderate to severe TBI are typically at risk of poor functional outcome in terms of neurocognitive impairment and behavior problems. Read more about this study

Who is it for?
Ages 6 to 14 yearsHealthy volunteers can take part
Conditions the study is for
MTBI - Mild Traumatic Brain Injury
What is being tested?
magnetic resonance image and gut microbiota
Type of treatment
Medical device
How many people
300 participants
Where
1 siteChina
Study dates
25 Oct 2021to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: All of the patients of mTBI group are in-patients and out-patients in the nephrology department from three research centers. The subjects of control group are recruited from community.

Who may be able to join

  • age 6-14 years at time of recruitment.
  • hospital admission with a clinical diagnosis of TBI for inclusion in the TBI group
  • GCS = 15-13.
  • loss of consciousness duration≤30 min.
  • post-traumatic amnesia duration ≤1 h.

Who cannot join

  • previous TBI.
  • visual or auditory disorder interfering with neurocognitive testing.
  • current neurological condition affecting the central nervous system with known effects on neurocognitive functioning, other than TBI.

Trial locations and contacts

1 site in 1 country.

Ming Zhang, phD contact

0086-18991232265

zmmri@163.com

China1 site, 1 recruiting
  • First Affiliated Hospital of Xian Jiaotong University

    Xi'an, Shaanxi, 710061

    Ming Zhang, PhD, 0086-18991232265, zmmri@163.com

    Lijun Bai, PhD, 0086-15129034948, bailijun@xjtu.edu.cn

    Recruiting

Other trials in China

About this study

Traumatic brain injury (TBI) is the leading cause of disability in children and young adults. Children with moderate to severe TBI are typically at risk of poor functional outcome in terms of neurocognitive impairment and behavior problems. Neurocognitive impairments include deficits in attention and working memory, learning and memory, and executive functioning, whereas behavior problems include anxiety, depression and aggression. Neuroimaging techniques based on multi-modal magnetic resonance image (MRI) can detect the structural and functional brain abnormalities objectively and sensitively. Recent evidence indicates that even after mild TBI, children with risk factors for intracranial pathology are at risk of poor neurocognitive and behavioral outcome.Meanwhile, recently, the concept of "gut-brain axis" has been proposed and hint gut microbiota could shape the brain. Some studies have emphasized that human gut microbiota plays an important role in the pathogenesis and development of TBI. However, how the gut affects the brain in patients with TBI is unclear. Thus, combining analysis of neuroimaging and "gut-brain axis" will provide more information for finding the risk factors and imaging diagnostic markers of brain impairment in TBI. It will also helpful for explaining the underlying mechanisms of brain impairment in TBI, providing an objective basis for clinical diagnosis and prediction of the prognosis.

Being tested
magnetic resonance image, gut microbiota
Keywords
Mild Traumatic Brain Injury, MRI, gut microbiota
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • magnetic resonance imageDevice

    Imaging data were collected in a strong magnetic field

  • gut microbiotaOther

    gut microbiota

Study groups in NCT05090007
Study groupRoleWhat they receive
mTBIA TBI is caused by a bump, blow, or jolt to the head that disrupts the normal function of the brain. Not all blows or jolts to the head result in a TBI.
Receives: Device: magnetic resonance image; Other: gut microbiota
HCHealthy controls
Receives: Device: magnetic resonance image; Other: gut microbiota

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline brain structure measures at 6 months and 12months

    The changes of brain volume (mm3) are evaluated by structural MRI

    Measured: baseline (early injury), post-traumatic for 6 months and 12 months

  2. Change from baseline brain function measures at 6 months and 12months

    The changes of brain functional connectivity intensity are evaluated by functional MRI

    Measured: baseline (early injury), post-traumatic for 6 months and 12 months

Secondary outcomes (3)
  1. Changes from baseline cognitive condition at 6 months and 12months

    The cognitive condition is assessed by Wechsler Intelligence Scale for Children-IV-Chinese Version (WISC-IV), higher scores represent better cognitive.

    Measured: baseline (early injury), post-traumatic for 6 months and 12 months

  2. Changes from baseline behavior condition at 6 months and 12months

    the neuro-behavior condition is assessed by child behavior checklist(CBCL),higher scores represent better behavior symptoms.

    Measured: baseline (early injury), post-traumatic for 6 months and 12 months

  3. Changes from baseline gut microbiota at 6 months and 12months

    Fecal samples were collected within 2 days before or after MR examination

    Measured: baseline (early injury), post-traumatic for 6 months and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2021
  2. Study start25 Oct 2021
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05090007
Sponsor's protocol ID
82071993
Status last verified
Apr 2022
First submitted
10 Oct 2021
Last updated
10 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of MTBI - Mild Traumatic Brain Injury, run by First Affiliated Hospital Xi'an Jiaotong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ming Zhang, phD (0086-18991232265, zmmri@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline brain structure measures at 6 months and 12months (time frame: baseline (early injury), post-traumatic for 6 months and 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in